Processing your payment...
Please do not close your browser.

Hemostasis and Tissue Sealing Agents Market- Global Growth, Trends and Forecast (2022 - 2029) By Product (Topical Hemostat, Adhesives & Tissue Sealant) By Regions

05 Jul, 2022 | 137 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the next five years, the Hemostasis and Tissue Sealing Agents Market will register a CAGR of 8.5 % in revenue, and the global market size will reach USD 10 Billion by 2029.

Hemostasis and Tissue Sealing Agents Market Overview

In a variety of situations, hemostasis tools and sealants are employed to stop blood loss. Its usage has increased in a variety of circumstances, particularly in endoscopic operations, because of the preference for these products over other wound closure techniques. The market for hemostasis and tissue sealing products serves patients with anything from minor wounds to burns and neurosurgical treatment. Hemostatic products have found a wide range of applications in urological therapies since 2006, following research completed and published by the National Centre for Biotechnology Information. Hemostatic agents are used often during minimally invasive urological procedures, which is fueling market expansion.

The number of surgical treatments is anticipated to climb along with the prevalence of chronic illnesses worldwide. It is also anticipated that this would increase the need for care for wound healing and closure. About 150 million Americans, according to the CDC, have at least one chronic illness that necessitates surgery.

What are our Hemostasis and Tissue Sealing Agents Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029

 

CAGR of 8.5 % during the review period (2022 to 2029).

 

By Product

 

 

 

 

  • Topical Hemostat
  • Adhesives
  • Tissue Sealant

 

 

 

By Companies

  • Johnson & Johnson
  • Cryolife Inc.
  • Baxter International Inc
  • Ethicon LLC
  • Integra Lifesciences Corporation
  • Becton
  • Dickinson & Company
  • Cohera Medical Inc.
  • Pfizer Inc
  • Medtronic plc
  • B. Braun Melsungen AG

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Historical Year

 

2017 to 2021

Forecast Year

2022 to 2029

Number of Pages

137

 

Customization Available

 

Yes, the report can be customized as per your needs

Frequently Asked Questions

What is the current market size and compound annual growth rate (CAGR) of the Hemostasis and Tissue Sealing Agents Market during the forecast period (2022-2029)?

The Hemostasis and Tissue Sealing Agents Market are growing at a CAGR of 8.5 % over the next 7 years.

Who are the key players in Hemostasis and Tissue Sealing Agents Market?

Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical Inc., Pfizer Inc, Medtronic plc, B. Braun Melsungen AG, and Others.

What region do this Hemostasis and Tissue Sealing Agents Market report covers?

North America (the United States, Canada, and Mexico), Europe (Germany, France, UK, Russia, and Italy), Asia-Pacific (China, Japan, Korea, India, and Southeast Asia), South America (Brazil, Argentina, Colombia, etc.), The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant Products of the Hemostasis and Tissue Sealing Agents Market?

Topical Hemostat, Adhesives, Tissue Sealant

Who are the Major Players in Hemostasis and Tissue Sealing Agents Market?

Market Growth Reports lists out all the Hemostasis and Tissue Sealing Agents Market companies that are presently striving to reduce the impact of Covid-19 pandemic on the Market- Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical Inc., Pfizer Inc, Medtronic plc, B. Braun Melsungen AG, Others

Industry News:

Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent In A Pad Form

Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form Plainsboro, New Jersey, September 24, Integra LifeSciences Holdings Corporation announced that its Integra NeuroSciences division has begun marketing the Helitene; Absorbable Collagen Hemostatic Agent in a 35mm x 70mm pad form. The product received a PMA supplement approval from the United States Food and Drug Administration for an indication for use in surgical procedures with the added flexibility of a pad form as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical

What are the major Products for Hemostasis and Tissue Sealing Agents Market?

By-Products it is segmented into

  • Topical Hemostat
  • Adhesives
  • Tissue Sealant

Hemostasis and Tissue Sealing Agents Market Regional Analysis

Due to the rising incidence of cancer, diabetes, and cardiovascular diseases there, North America held the greatest market share. A sizable portion of the North American market is made up of adhesives and sealants. The projection period will see a CAGR of almost 8.0 percent in Europe, which represented the second-largest market in 2018. The introduction of cutting-edge and ground-breaking goods like FLOSEAL, TISEEL, and HEMOPATCH is anticipated to boost demand from European nations. The growing elderly population in the region is anticipated to fuel the regional market, which eventually results in more surgeries.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America
  1. INTRODUCTION
    1. MARKET DEFINITION
    2. MARKET DYNAMICS
    3. MARKET SEGMENTATION
    4. REPORT TIMELINES
    5. KEY STAKEHOLDERS
  2. RESEARCH METHODOLOGY
    1. DATA MINING
      1. SECONDARY RESEARCH
      2. PRIMARY RESEARCH
      3. SUBJECT MATTER EXPERT ADVICE
    2. QUALITY CHECK
    3. FINAL REVIEW
      1. DATA TRIANGULATION
      2. BOTTOM-UP APPROACH
      3. TOP-DOWN APPROACH
      4. RESEARCH FLOW
  3. EXECUTIVE SUMMARY
    1. INTRODUCTION
    2. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS BY PRODUCT
  4. MARKET DYNAMICS
    1. DRIVERS
      1. INCREASING DEMAND FOR MSM SUPPLEMENT
    2. RESTRAINTS
      1. STRINGENT ENVIRONMENTAL REGULATIONS
      2. HIGH COST OF MATERIALS
    3. OPPORTUNITIES
      1. HEMOSTASIS AND TISSUE SEALING AGENTS GROWTH
    4. APPLICATION OF HEMOSTASIS AND TISSUE SEALING AGENTS IMPACT OF COVID 19
  5. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS, BY PRODUCT
    1. INTRODUCTION
    2. TOPICAL HEMOSTAT
    3. ADHESIVES
    4. TISSUE SEALANT 
  6. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS, BY REGION
    1. NORTH AMERICA
      1. US
      2. CANADA
      3. MEXICO
    2. EUROPE
      1. GERMANY
      2. FRANCE
      3. UK
      4. ITALY
      5. RUSSIA
      6. REST OF EUROPE
    3. APAC
      1. CHINA
      2. SOUTH KOREA
      3. JAPAN
      4. INDIA
      5. AUSTRALIA
      6. ASEAN
      7. REST OF APAC
    4. MIDDLE EAST & AFRICA
      1. SAUDI ARABIA
      2. UAE
      3. SOUTH AFRICA
      4. TURKEY
      5. REST OF MEA
    5. SOUTH AMERICA
      1. BRAZIL
      2. REST OF MEA
      3. ARGENTINA
      4. REST OF SOUTH AMERICA
  7. COMPETITIVE LANDSCAPE
    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
    2. AND AGREEMENTS
      1. KEY DEVELOPMENT
    3. MARKET SHARE PERCENT/RANKING ANALYSIS
    4. STRATEGIES ADOPTED BY LEADING PLAYERS
  8. COMPANY PROFILES
    1. BUSINESS OVERVIEW
    2. COMPANY SNAPSHOT
    3. PRODUCT BENCHMARKING
    4. STRATEGIC INITIATIVES
      1. JOHNSON & JOHNSON
      2. CRYOLIFE INC.
      3. BAXTER INTERNATIONAL INC
      4. ETHICON LLC
      5. INTEGRA LIFESCIENCES CORPORATION
      6. BECTON
      7. DICKINSON & COMPANY
      8. COHERA MEDICAL INC.
      9. PFIZER INC
      10. MEDTRONIC PLC
      11. B. BRAUN MELSUNGEN AG

 

 

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla